These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9519169)

  • 21. Problems of anticoagulation within a palliative care setting: an audit of hospice patients taking warfarin.
    Johnson MJ
    Palliat Med; 1997 Jul; 11(4):306-12. PubMed ID: 9373582
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Outpatient management of anticoagulation therapy.
    du Breuil AL; Umland EM
    Am Fam Physician; 2007 Apr; 75(7):1031-42. PubMed ID: 17427618
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Low-molecular-weight heparin in cancer-associated thrombosis: treatment, secondary prevention, and survival.
    Nishioka J; Goodin S
    J Oncol Pharm Pract; 2007 Jun; 13(2):85-97. PubMed ID: 17873108
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Venous thromboembolism.
    Gera R; Kulkarni R
    Indian J Pediatr; 1999; 66(2):163-9. PubMed ID: 10798054
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Prevention of venous thromboembolism in cancer patients.
    Kakkar AK; Williamson RC
    Semin Thromb Hemost; 1999; 25(2):239-43. PubMed ID: 10357091
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does antithrombotic therapy improve survival in cancer patients?
    Cunningham MS; Preston RJ; O'Donnell JS
    Blood Rev; 2009 May; 23(3):129-35. PubMed ID: 19046797
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The use of low molecular weight heparins for the prevention of postoperative venous thromboembolism in general surgery. A survey of practice in the United States.
    Caprini JA; Arcelus J; Sehgal LR; Cohen EB; Reyna JJ
    Int Angiol; 2002 Mar; 21(1):78-85. PubMed ID: 11941278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dose escalation of low molecular weight heparin in patients with recurrent cancer-associated thrombosis.
    Ihaddadene R; Le Gal G; Delluc A; Carrier M
    Thromb Res; 2014 Jul; 134(1):93-5. PubMed ID: 24835673
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Management of thromboembolism in patients with cancer.
    Viale PH
    Oncol Nurs Forum; 1999; 26(10):1625-32; quiz 1633-4. PubMed ID: 10573679
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Predictors and safety of venous thromboembolism prophylaxis among hospitalized inflammatory bowel disease patients.
    Ra G; Thanabalan R; Ratneswaran S; Nguyen GC
    J Crohns Colitis; 2013 Nov; 7(10):e479-85. PubMed ID: 23537817
    [TBL] [Abstract][Full Text] [Related]  

  • 31. VTE prophylaxis for the medical patient: where do we stand? - a focus on cancer patients.
    Cohen AT; Nandini B; Wills JO; Ota S
    Thromb Res; 2010 Apr; 125 Suppl 2():S21-9. PubMed ID: 20434000
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knowledge and Awareness of Venous Thromboembolism in Intensive Care Units in Zhejiang Province, China: A Cross-Sectional Survey.
    Yan J; Zhou J; Zhen J; Li L; Care Clinical Research Group ZPC
    Med Sci Monit; 2020 Jun; 26():e923378. PubMed ID: 32544921
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Antithrombotic drugs for older subjects. Guidelines formulated jointly by the Italian Societies of Haemostasis and Thrombosis (SISET) and of Gerontology and Geriatrics (SIGG).
    Di Minno G; Tufano A; Cerbone AM
    Nutr Metab Cardiovasc Dis; 2001 Feb; 11(1):41-62. PubMed ID: 11383324
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Prevention and treatment of venous thromboembolism in patients with solid brain neoplasms: results of a survey among Italian physicians.
    Mumoli N; Barco S; Cei M; Giorgi-Pierfranceschi M; Campanini M; Fontanella A; Ageno W; Dentali F
    Intern Emerg Med; 2017 Jun; 12(4):437-443. PubMed ID: 27878663
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Warfarin should not be used for thromboprohylaxis in elective major orthopaedic surgery: a Croatian perspective.
    Kolundžić R; Šimić Jovičić M; Ðinkić M; Petrović T; Crnković T; Trkulja V
    Med Glas (Zenica); 2017 Aug; 14(2):244-249. PubMed ID: 28698538
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Treatment of venous thromboembolism: adherence to guidelines and impact of physician knowledge, attitudes, and beliefs.
    Caprini JA; Tapson VF; Hyers TM; Waldo AL; Wittkowsky AK; Friedman R; Colgan KJ; Shillington AC;
    J Vasc Surg; 2005 Oct; 42(4):726-33. PubMed ID: 16242561
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Periprocedural anticoagulation management of patients with venous thromboembolism.
    McBane RD; Wysokinski WE; Daniels PR; Litin SC; Slusser J; Hodge DO; Dowling NF; Heit JA
    Arterioscler Thromb Vasc Biol; 2010 Mar; 30(3):442-8. PubMed ID: 20139361
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Venous Thromboembolism Prophylaxis For Esophagectomy: A Survey of Practice Patterns Among Thoracic Surgeons.
    Zwischenberger BA; Tzeng CW; Ward ND; Zwischenberger JB; Martin JT
    Ann Thorac Surg; 2016 Feb; 101(2):489-94. PubMed ID: 26409709
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multidisciplinary initiative to improve inpatient anticoagulation and management of venous thromboembolism.
    Maynard G; Humber D; Jenkins I
    Am J Health Syst Pharm; 2014 Feb; 71(4):305-10. PubMed ID: 24481155
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Primary thromboprophylaxis in the palliative care setting: a qualitative systematic review.
    McLean S; Ryan K; O'Donnell JS
    Palliat Med; 2010 Jun; 24(4):386-95. PubMed ID: 20360427
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.